Business Context and Reporting Period
This Form 8-K is a current report filed by NanoVibronix, Inc. (trading symbol: NAOV) on November 18, 2019. The filing documents events occurring at a special meeting of stockholders held on that date. Note: The input metadata references "Envue Medical, Inc.", but the filing text explicitly identifies the registrant as NanoVibronix, Inc.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate governance and capital structure amendments rather than financial performance results.
Material Changes and Corporate Actions
- Authorized Preferred Stock Increase: Stockholders approved an amendment to the Certificate of Incorporation to increase authorized preferred stock from 5,000,000 to 11,000,000 shares.
- Stock Issuance Approvals:
- Proposal 1: Approved issuance of common stock upon conversion of Series E convertible preferred stock and related warrants issued in private placements (June and July 2019).
- Proposal 2: Approved issuance of common stock and warrant-convertible shares to a director.
- Voting Results: Out of 4,778,582 shares entitled to vote, 2,759,671 were voted. All four proposals received overwhelming support with over 2.75 million votes "For" and fewer than 3,000 votes "Against" or "Abstentions" for each proposal.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, or specific risk factors beyond the standard incorporation of exhibits. The primary focus is the successful execution of the stockholder vote and the subsequent filing of the Certificate of Amendment with the Delaware Secretary of State on November 20, 2019.
Investor Verification Checklist
- Verify the exact terms of the Series E convertible preferred stock and associated warrants referenced in Proposal 1.
- Confirm the specific details of the stock issuance to the director under Proposal 2.
- Review Exhibit 3.1 (Certificate of Amendment) for the full legal text regarding the increase in authorized preferred shares.
- Check subsequent filings to confirm the actual issuance of shares following these approvals.